Ethyl 4-chloroacetoacetate → HCID 14207605, 화합물

HRID 1086172노트

반응식

HRID 1086172 반응식
[NH2:1][C:2]1[C:7]([NH:8][CH3:9])=[N:6][C:5]([Br:10])=[CH:4][N:3]=1.Cl[CH2:12][C:13]([CH2:15][C:16]([O:18][CH2:19][CH3:20])=[O:17])=O>CN(C)C=O>[Br:10][C:5]1[N:6]=[C:7]([NH:8][CH3:9])[C:2]2[N:3]([CH:12]=[C:13]([CH2:15][C:16]([O:18][CH2:19][CH3:20])=[O:17])[N:1]=2)[CH:4]=1

참가 물질

4

실험 절차

2.03 g (10 mmol) of 2-amino-5-bromo-3-methylaminopyrazine are dissolved in 5 ml of dimethylformamide (DMF). A solution of 1.645 g(10 mmol) of ethyl (chloroacetyl)acetate in 5 ml of DMF is added dropwise with stirring. The mixture is maintained with stirring and under gentle reflux for 3 hours. The DMF is then evaporated off under reduced pressure and the residue, dissolved in 50 ml of anhydrous ethanol, is brought to reflux for one hour. After removal of the solvent, the residue is taken up with water, alkalinized and extracted with dichloromethane. After dehydration over anhydrous calcium chloride, the solvent is evaporated off under reduced pressure. The crude product is purified by chromatography on a silica column (eluant=dichloromethane to which 5% of methanol has been added). 0.4 g (Yld=30%) of ethyl 6-bromo-8-methylaminoimidazo[1,2-a]pyrazine-2-acetate (m.p. 104° C.) is obtained.

후처리

  1. temperatureThe mixture is maintained
  2. stirringwith stirring
  3. temperatureunder gentle reflux for 3 hours
  4. customThe DMF is then evaporated off under reduced pressure
  5. dissolutionthe residue, dissolved in 50 ml of anhydrous ethanol
  6. temperatureto reflux for one hour
  7. customAfter removal of the solvent
  8. extractionextracted with dichloromethane
  9. customAfter dehydration over anhydrous calcium chloride, the solvent is evaporated off under reduced pressure
  10. customThe crude product is purified by chromatography on a silica column (eluant=dichloromethane to which 5% of methanol has been added)

출처 및 근거

ORD 기록
ord-79cce7a7c39949959beb7fa26d3256e6
출처 데이터셋
uspto-grants-1991_07
특허 번호
US05028605

반응 노트

불러오는 중…